Noncoding RNA CCDC26 regulates KIT expression

A long, noncoding RNA (lncRNA), which might have impact on tyrosine kinase-targeted leukemia therapy, was found to be expressed in a leukemia cell line. The function of the lncRNA CCDC26 is not fully understood; however, researchers at Hiroshima University revealed the mechanisms by which CCDC26 controls the receptor tyrosine kinase KIT expression. The results provide new insights into leukemia recurrence and may help to develop new leukemia therapies.

Recent transcriptomic studies have revealed the existence of numerous RNAs that are relatively long but not translated into proteins. Some of these lncRNAs are suggested to regulate the expression of other genes. Mutations or imbalances in the noncoding RNA repertoire within the body can therefore cause a variety of diseases such as cancer. However, the molecular functions of lncRNAs remain to be fully elucidated.

Dr. Tetsuo Hirano from the Graduate School of Integrated Arts and Science at Hiroshima University found that knockdown of the CCDC26 gene in cells results in significant upregulation of the KIT gene, hyperactive mutations of which are often found in .

Dr. Hirano and his collaborators at the School of Medicine in Juntendo University showed that CCDC26 transcript levels are high in the nuclear fraction of human myeloid cell lines. They also found that CCDC26 knockdown induces suppression of CCDC26 intron-containing transcripts, indicating transcriptional gene suppression. Leukemia cells in which CCDC26 was knocked down showed enhanced survival periods after serum withdrawal. A KIT-specific inhibitor reversed this increased survival of the cells. These results are published in a Molecular Cancer article titled "Long noncoding RNA, CCDC26, controls myeloid growth through regulation of KIT expression."

"We suggested that CCDC26 controls growth of cells through regulation of KIT expression. Abnormal CCDC26 RNA structure could modulate the regulation of KIT to induce undesired overexpression. Leukemia characterized by a mutated copy number of CCDC26 might be treated by KIT-targeted therapy," says Dr. Hirano.


Explore further

Long noncoding RNAs: A novel prognostic marker in older patients with acute leukemia

More information: "Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression," Molecular Cancer, 2015. DOI: 10.1186/s12943-015-0364-7
Provided by Hiroshima University
Citation: Noncoding RNA CCDC26 regulates KIT expression (2015, June 2) retrieved 21 October 2019 from https://medicalxpress.com/news/2015-06-noncoding-rna-ccdc26-kit.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
18 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more